These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3510949)

  • 1. Vasopressin analogs in portal hypertension: different molecules but similar questions.
    Blei AT
    Hepatology; 1986; 6(1):146-7. PubMed ID: 3510949
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
    Testro AG; Angus PW
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1707-9. PubMed ID: 20136956
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy for portal hypertension.
    Lebrec D
    Gut; 2001 Sep; 49(3):441-2. PubMed ID: 11511569
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient with a sudden drop in blood pressure.
    Oliver JA; Landry DW
    Crit Care Med; 2003 Jan; 31(1):326-7. PubMed ID: 12545047
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasopressin and terlipressin in neonates and children with refractory septic shock.
    Biban P; Gaffuri M
    Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin and terlipressin in adult vasodilatory shock.
    Polito A; Parisini E; Ricci Z; Picardo S; Annane D
    Crit Care; 2012 Dec; 16(6):470; author reply 470. PubMed ID: 23273051
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vasopressin and terlipressin in sepsis and systemic inflammatory response syndrome. Effects on microcirculation, oxygen transport, metabolism and organ function].
    Ertmer C; Sielenkämper AW; van Aken H; Bone HG; Westphal M
    Anaesthesist; 2005 Apr; 54(4):346-56. PubMed ID: 15625598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.
    Møller S; Hansen EF; Becker U; Brinch K; Henriksen JH; Bendtsen F
    Liver; 2000 Feb; 20(1):51-9. PubMed ID: 10726961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on "Role of vasopressin in the management of septic shock" by Mutlu and Factor.
    Dünser MW; Mayr AJ; Wenzel V; Hasibeder WR
    Intensive Care Med; 2004 Oct; 30(10):1982; author reply 1983. PubMed ID: 15278269
    [No Abstract]   [Full Text] [Related]  

  • 11. Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension.
    Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Hou MC; Wu SL; Tai CC; Chan CC; Lee SD
    Clin Sci (Lond); 1998 Nov; 95(5):629-36. PubMed ID: 9791050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Terlipressin in the treatment of portal hypertension].
    Primo J; Molés JR; Fernández J; Llorca P; Hinojosa J
    Gastroenterol Hepatol; 1999 May; 22(5):258-60. PubMed ID: 10396111
    [No Abstract]   [Full Text] [Related]  

  • 13. Doppler evaluation of the effects of pharmacological treatment of portal hypertension.
    Piscaglia F; Gaiani S; Donati G; Masi L; Bolondi L
    Ultrasound Med Biol; 1999 Jul; 25(6):923-32. PubMed ID: 10461720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of portal hypertension.
    Patch D; Burroughs AK
    Prog Liver Dis; 1995; 13():269-92. PubMed ID: 9224506
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of the novel vasotocin analogue F-180 vs. vasopressin and terlipressin on systemic and splanchnic isolated vessels from portal hypertensive rats.
    Ramírez MC; Martínez-Cuesta MA; D'Ocon P; Noguera MA; García-Zaragoza E; Bosch J; Melin P; Esplugues JV
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):199-204. PubMed ID: 11521161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Terlipressin in the treatment of septic shock: the earlier the better"?
    Morelli A; Ertmer C; Westphal M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):317-21. PubMed ID: 18683477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy.
    Ari E; Yilmaz Y; Kedrah AE; Alahdab Y; Cakalagaoglu F; Arikan H; Kocak H; Macunluoglu B; Atakan A; Kahveci A; Asicioglu E; Tuglular S; Ozener C
    Am J Nephrol; 2011; 33(3):269-76. PubMed ID: 21372562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive epidermal necrosis due to terlipressin.
    Yefet E; Gershovich M; Farber E; Soboh S
    Isr Med Assoc J; 2011 Mar; 13(3):180-1. PubMed ID: 21608341
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute variceal bleeding: pharmacological treatment and primary/secondary prophylaxis.
    Dell'Era A; de Franchis R; Iannuzzi F
    Best Pract Res Clin Gastroenterol; 2008; 22(2):279-94. PubMed ID: 18346684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.